A new pill that promises to help endometriosis sufferers deal with the chronic disease’s debilitating symptoms was approved ...

The first-of-its-kind endometriosis pill provides hope for 1.5 million people in the UK affected by the condition ...

However, speaking to HuffPost UK, Hannah Travis, an associate in the medical negligence team at Bolt Burdon Kemp who focuses ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

The first daily pill for long-term treatment of endometriosis has been approved for use across England by the National Health ...

A daily pill to treat the symptoms of endometriosis will soon be made available on the NHS, in a move that could benefit 1000 women a year in England.1 The National Institute for Health and Care ...

Endometriosis causes chronic pain and fatigue when tissue similar to the womb lining grows outside the uterus. With diagnosis often taking up to 9 years, the availability of additional treatment ...

The NHS has approved a new pill that is designed to transform the treatment of endometriosis. The combination drug will help around 1,000 women every year in England who suffer from the debilitating ...

Unlike Elon Musk, Keir Starmer did not brandish a chainsaw to underline his commitment to reducing bureaucracy – but he might ...